Wells Fargo sees the appointment of Ashley McEvoy as CEO of Insulet (PODD) as a significant positive for the company given McEvoy’s experience and track record. Wells look forward to hearing about her vision for the company on the May 8 earnings call. The firm has an Overweight rating on the shares with a price target of $322.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD:
- Insulet names Ashley McEvoy as President and CEO, succeeding Jim Hollingshead
- Insulet expects to exceed previously issued Q1 revenue guidance
- Insulet price target lowered to $325 from $340 at RBC Capital
- Insulet Closes $450 Million Senior Notes Issuance
- Insulet’s Strong Performance and Growth Prospects Drive Buy Rating